Neurofibromatosis Type 1—An Update and Review for the Primary Pediatrician
Authors:
- Kurt DibbernKDKurt Dibbern
- 1 November 1996
- journal article
- review article
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 35 (11) , 545-561
Abstract
With an incidence of 1 in 3,000, neurofibromatosis type 1 (NFl), or von Recklinghausen disease, is one of the most common genetic disorders encountered by primary care physicians. NFI is a multisystem disease that affects more than one million people worldwide (more than 80,000 in the United States). Although most pediatricians have patients with NFl in their practices, many affected individuals go undiagnosed as children. This article is intended to facilitate the diagnosis and management of young patients with NFl.Keywords
This publication has 17 references indexed in Scilit:
- Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestationsAmerican Journal of Medical Genetics, 1995
- Neurofibromatosis Type 1 Due to Germ-Line Mosaicism in a Clinically Normal FatherNew England Journal of Medicine, 1994
- Screening for truncated NF1 proteinsNature Genetics, 1994
- Proteus syndrome: Clinical evidence for somatic mosaicism and selective reviewAmerican Journal of Medical Genetics, 1993
- Type 1 neurofibromatosis and the pediatric patientCurrent Problems in Pediatrics, 1992
- G protein Gsα (GNAS1), the probable candidate gene for albright hereditary osteodystrophy, is assigned to human chromosome 20q12–q13.2Genomics, 1991
- The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteinsCell, 1990
- Paternal origin of new mutations in Von Recklinghausen neurofibromatosisNature, 1990
- The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutationsAmerican Journal of Medical Genetics, 1984
- Von Recklinghausen NeurofibromatosisNew England Journal of Medicine, 1981